Reduction of Left Ventricular Hypertrophy After Eplerenone Therapy

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 125 participants.

Also called NCT03186742

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 125 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03186742
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Not reported
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03186742. Randomized; no masking; primary purpose treatment. Start 2014-07-01 (actual); primary completion 2017-01-01 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Reduction of Left Ventricular Hypertrophy After Eplerenone Therapy
Condition
Hypertension,Essential
Condition
Obstructive Sleep Apnea
Condition
Left Ventricular Hypertrophy
Intervention (Drug)
Eplerenone 50 mg Tab
Lead sponsor
Poznan University of Medical Sciences (class: other)

Record details

Record id
cardio:ct-nct03186742
Content hash
2137d8c2067cd60d4106c969b9d75a656df749fa38d35503c93d5ad5e3f0e369